|
Hear Focused Sessions on:
• Bridging Biodefense and Clinical Applications
• Integrating Point-of-Care Devices in Clinical Practice
• Detecting Pathogens and Rapid Screening
|
Strategic and Technical
Presenters Include:
|
 |
Steven Buchsbaum, Ph.D., Senior Program Officer, Global
Health Technologies, Bill & Melinda Gates Foundation
|
 |
Klaus O. Schäfer, M.D., MPH, President & CEO, Tessarae
Inc./LLC
|
|
|
|
|
 |
Giorgio Roscigno, M.D., Chief Executive Officer, FIND
Diagnostics
|
 |
Emily S. Winn-Deen, Ph.D., Vice President, Strategic
Planning and Business Development, Cepheid
|
|
|
|
|
 |
Sally A. Hojvat, MSc, Ph.D., Director, Division of
Microbiology Devices, Food and Drug Administration
|
 |
Lucy Lu, Ph.D., Vice President, Technology Management,
Head, US Chief Technology Office, Roche Diagnostics
Miniaturization and Integration of Clinical Chemistry and PCR-Based
Nucleic Acid Testing Platforms
|
|
|
|
|
 |
John C. Carrano, Ph.D., Vice President, Research and Development,
Luminex Corporation
|
 |
Eric Van Gieson, Ph.D., Program Manager, Johns Hopkins
Applied Physics Laboratory
|
|
|
|
|
 |
Donna Boston, JBAIDS Program Manager, Office of the Joint
Project Manager Chemical Biological Medical Systems
|
|
Barry E. Boyes, Ph.D., Vice President of Biological Product Development, Smiths Detection
|
|
|
|
|
 |
Penny Wilson, Ph.D., Independent Consultant, Diagnostic
Specialist
|
 |
Michael Londner, M.D., MPH, MBA,
Assistant Professor, The Johns Hopkins University School of
Medicine |
|
|
|
|
 |
Janet A. Warrington, Ph.D., Vice President, Research and
Development, Affymetrix Inc.
|
|
|
|
Don’t Miss
|
Immediately Following the 6th Annual
Systems Integration in Biodefense
August 13-14, 2007
|
|
|
